4
Changes in Ownership
ALX ONCOLOGY HOLDINGS INC Filed Acc 0001209191-22-007887
Chief Financial Officer acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GARCIA PETER S Chief Financial Officer | 2022-02-07 | Option exercise | +6,637 | $4.08 | $27,079 | 16,120 | D: show line 1 in the form |
| GARCIA PETER S Chief Financial Officer | 2022-02-07 | Option exercise | +8,363 | $4.81 | $40,226 | 24,483 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| GARCIA PETER S Chief Financial Officer | 2022-02-07 | Option exercise · Employee Stock Option (right to buy) | −6,637 | 89,022 | D: show line 3 in the form | |||||
| GARCIA PETER S Chief Financial Officer | 2022-02-07 | Option exercise · Employee Stock Option (right to buy) | −8,363 | 20,813 | D: show line 4 in the form |
Loading xslF345X03/doc4.xml…